Publications

2015
4 February

The EU-US trade deal could leave Europeans sick
16 January

Innovative Global Study Launched to Improve Access to Insulin
1 January

HAI Europe Workplan 2015
2014
22 October

Retention of Medicines Policy in DG Health a Victory for Public Health Advocates
16 October

EMA’s Final Policy on Access to Clinical Data: Proactive Access to Some Data, But Strings Attached
14 October

EU Pharmacovigilance Public Hearings Should Be As Transparent and Independent as in US
29 September

Trading Away Access to Medicines – Revisited
29 September

Europe Seeks to Expand Big Pharma Monopoly at Expense of Poor People, Warn NGOs Ahead of TTIP Talks (2014)
12 September

Public Health in Danger with Move of Pharmaceutical Policy to DG Enterprise and Industry
1 September

Mapping External Reference Pricing Practices for Medicines
15 July

Providing Scientific Advice to Pharma Industry Undermines Independence of Regulatory Authorities
14 July

Investor-State Dispute Settlement in EU-US Trade Deal Risks Access to Affordable Medicines
24 June

EMA’s New Policy on Access to Clinical Data – About to Privatise Pharmaceutical Knowledge?
5 June

Variations in Prices and Reimbursement of Medicines in the European Union
22 May

HAI Europe Urges EMA Not to Backtrack on Commitments to Clinical Trial Data Transparency
22 May

Act Now or Face Catastrophic Post-antibiotic Era: Global Civil Society Coalition Issues Grave Warning to WHA
22 April

Declaration on Antibiotic Resistance (Antibiotic Resistance Coalition)
3 April

Health Action International Welcomes Adoption of New Clinical Trials Regulation by European Parliament
3 April

Health Action International Applauds Medicines Patent Pool, ViiV Healthcare Licensing Agreement for New HIV Treatment
24 March

The EU-US Trade Agreement – Proposals by Pharmaceutical Industry Undermine European Public Policymaking and Public Health
17 March

EU Regulation on Clinical Trials – Close to the Finish Line
12 March

Corporate Interests Should Not Trump Access to Medicines for EU Citizens in Secret TTIP Negotiations
3 March

2013 Annual Report and Financial Statements
1 March

2013 Annual Report and Financial Statements
1 February

Working Paper 4 – Competition Policy
1 February

Policy Brief 3 – Regulation of Mark-ups in the Pharmaceutical Supply Chain
1 February

Policy Brief 5 – Sales Taxes on Medicines
1 February

Policy Brief 6 – The Role of Health Technology Assessment in Medicine Pricing and Reimbursement
1 February

Policy Brief 2 – The Role of Health Insurance in the Cost-effective Use of Medicines
1 February

Working Paper 1 – External Reference Pricing